Fecal levels in CRC


Ahlquist DA, Gilbert JA. Stool markers for colorectal screening: future considerations. Dig Dis 1996; 14(3): 132-44.
PMID#: 8861521

 

Brydon WG, Campbell SS, Anderson NA, Wilson RG, Ghosh S. Faecal calprotectin levels and colorectal neoplasia. Gut 2001; 48(4): 579-80.
PMID#: 11288736

 

Gilbert JA, Ahlquist DA, Mahoney DW, Zinsmeister AR, Rubin J, Ellefson RD. Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin. Scand J Gastroenterol 1996; 31(10):1001-5.
PMID#: 8898421

 

Johne B, Kronborg O, Ton HI, Kristinsson J, Fuglerud P. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Scand J Gastroenterol 2001; 36(3): 291-6.
PMID#: 11305517

 

Kristinsson J, Armbruster CH, Ugstad M, Kriwanek S, Nygaard K, Ton H, Fuglerud P. Fecal excretion of calprotectin in colorectal cancer; relationship to tumor characteristics. Scand J Gastroenterol 2001; 36(2):202-7.
PMID#: 11252414

 

Kristinsson J, Roseth A, Fagerhol MK, Aadland E, Schjonsby H, Bormer OP, Raknerud N, Nygaard K. Fecal calprotectin concentration in patients with colorectal carcinoma. Diseases of the Colon & Rectum1998; 41(3):316-21.
PMID#: 9514426

 

Kronborg O, Ugstad M, Fuglerud P, Johne B, Hardcastle J, Scholefield JH, Vellacott K, Moshakis V, Reynolds JR. Faecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 2000; 46(6):795-800.

PMID#: 10807890

 

Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27(9):793-8.

PMID#: 1411288

 

Roseth AG, Kristinsson J, Fagerhol MK, Schjonsby H, Aadland E, Nygaard K, Roald B. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 1993; 28(12):1073-6.

PMID#: 8303210

 

Tibble J, Sigthorsson G, Foster R, Fagerhol MK, Bjarnason I. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut 2001; 49: 402.
PMID#: 11511563

 

CALPRO TEAM

  • Anne Thjømøe

    Executive Chairman 

    Mail: athjomoe@calpro.no

    Direct line: +47 97 73 37 51

  • Anne Hancke Framstad

    Laboratory Quality Specialist

    E-mail: aframstad@calpro.no

    Direct line: +47 92 01 14 91

  • Einar Mørk

    Dir. Operations

    E-mail: einar@calpro.no

    Direct line: +47 47 28 55 61

  • Mona Schartum

    Production Manager

    E-Mail: mona.schartum@calpro.no

    Direct line: +47 93 22 73 63

  • Ingvild haukø bilde

    Ingvild Haukø

    Sales- and Marketing Manager

    e-mail: ingvild@calpro.no

    Direct line: +47 92 01 52 18

  • Ali Qamar

    Product Manager

    E-mail: ali@calpro.no

    Direct line: +47 41 17 81 19

General Information

Fecal calprotectin in differential diagnosis of irritable bowel syndrome

Li XG, Lv YM, Gu F, Yang XL., Department of Gastroenterology, Peking University Third May 9, 2015

PhiCal Test FDA approved

The PhiCal Test has now been approved by the FDA for clinical use in the USA October 1, 2014

Latest News

Calpro press release regarding MSD agreement

Please see the Calpro press release regarding MDS agreement for delivery of e-health technology CalproSmart:

Norsk | English October 13, 2016

Calprosmart in the Media

Please see our latest articles regarding CalproSmart in Aftenposten and LMF Norge

LMF Norge | Aftenposten October 12, 2016

View all latest

Share This